236 related articles for article (PubMed ID: 16940419)
41. Regulatory abnormalities in the marrow of patients with myelodysplastic syndromes.
Merchav S; Nagler A; Fleischer-Kurtz G; Tatarsky I
Br J Haematol; 1989 Oct; 73(2):158-64. PubMed ID: 2479408
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiling in the myelodysplastic syndromes.
Pellagatti A; Fidler C; Wainscoat JS; Boultwood J
Hematology; 2005 Aug; 10(4):281-7. PubMed ID: 16085540
[TBL] [Abstract][Full Text] [Related]
43. Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.
Rowinsky EK; Donehower RC; Spivak JL; Burke PJ; Griffin CA; Jones RJ
J Natl Cancer Inst; 1990 Dec; 82(24):1926-31. PubMed ID: 2250314
[TBL] [Abstract][Full Text] [Related]
44. Bestatin treatment of myelodysplastic syndromes (MDS) and the effects of bestatin on hematopoiesis in MDS.
Uzuka Y; Saito Y
Acta Oncol; 1990; 29(6):803-7. PubMed ID: 2223153
[TBL] [Abstract][Full Text] [Related]
45. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
Sada E; Abe Y; Ohba R; Tachikawa Y; Nagasawa E; Shiratsuchi M; Takayanagi R
Eur J Haematol; 2010 Dec; 85(6):538-48. PubMed ID: 20887388
[TBL] [Abstract][Full Text] [Related]
46. Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy.
Silverman LR; Greenberg P; Raza A; Olnes MJ; Holland JF; Reddy P; Maniar M; Wilhelm F
Hematol Oncol; 2015 Jun; 33(2):57-66. PubMed ID: 24777753
[TBL] [Abstract][Full Text] [Related]
47. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
48. Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic Syndromes.
Aoyagi Y; Hayashi Y; Harada Y; Choi K; Matsunuma N; Sadato D; Maemoto Y; Ito A; Yanagi S; Starczynowski DT; Harada H
Cancer Discov; 2022 Jan; 12(1):250-269. PubMed ID: 34462274
[TBL] [Abstract][Full Text] [Related]
49. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
50. S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes.
Cheng P; Eksioglu EA; Chen X; Kandell W; Le Trinh T; Cen L; Qi J; Sallman DA; Zhang Y; Tu N; Adams WA; Zhang C; Liu J; Cleveland JL; List AF; Wei S
Leukemia; 2019 Aug; 33(8):2034-2046. PubMed ID: 30737486
[TBL] [Abstract][Full Text] [Related]
51. [Inhibition of hematopoiesis by sera from patients with myelodysplastic syndromes].
Ding R; Liu H; Xu R
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):515-7. PubMed ID: 11721395
[TBL] [Abstract][Full Text] [Related]
52. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A
Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
[TBL] [Abstract][Full Text] [Related]
53. APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.
Raimbault A; Pierre-Eugene C; Rouquette A; Deudon C; Willems L; Chapuis N; Mathis S; Kunz C; Fricke H; Kosmider O; Bardet V; Fontenay M;
Oncotarget; 2016 Mar; 7(12):14898-911. PubMed ID: 26910909
[TBL] [Abstract][Full Text] [Related]
54. Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis.
Kunze K; Gamerdinger U; Leßig-Owlanj J; Sorokina M; Brobeil A; Tur MK; Blau W; Burchardt A; Käbisch A; Schliesser G; Kiehl M; Rosenwald A; Rummel M; Grimminger F; Hain T; Chakraborty T; Bräuninger A; Gattenlöhner S
Pathol Res Pract; 2014 Jun; 210(6):369-76. PubMed ID: 24674452
[TBL] [Abstract][Full Text] [Related]
55. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
56. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.
Shetty V; Mundle S; Alvi S; Showel M; Broady-Robinson L; Dar S; Borok R; Showel J; Gregory S; Rifkin S; Gezer S; Parcharidou A; Venugopal P; Shah R; Hernandez B; Klein M; Alston D; Robin E; Dominquez C; Raza A
Leuk Res; 1996; 20(11-12):891-900. PubMed ID: 9009245
[TBL] [Abstract][Full Text] [Related]
57. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
[TBL] [Abstract][Full Text] [Related]
58. Bone marrow colony-forming unit assay in cats with naturally occurring myelodysplastic syndromes.
Nagashima N; Hisasue M; Higashi K; Kano R; Tsujimoto H; Hasegawa A
Int J Hematol; 2001 Jun; 73(4):453-456. PubMed ID: 11503958
[TBL] [Abstract][Full Text] [Related]
59. The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome.
Yang WC; Lin SF; Wang SC; Tsai WC; Wu CC; Wu SC
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344823
[TBL] [Abstract][Full Text] [Related]
60. SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes.
Giles FJ; Stopeck AT; Silverman LR; Lancet JE; Cooper MA; Hannah AL; Cherrington JM; O'Farrell AM; Yuen HA; Louie SG; Hong W; Cortes JE; Verstovsek S; Albitar M; O'Brien SM; Kantarjian HM; Karp JE
Blood; 2003 Aug; 102(3):795-801. PubMed ID: 12649163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
